Search - tctmd.com

Displaying 21 - 40 of 63

Sort: Relevancy | Date

News Conference News TCT 2019

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

Michael O'Riordan

September 25, 2019

Presentation TCT 2019

TCT 79: Multimodality Assessment of Prosthetic Valve Regurgitation to Predict Reverse Cardiac Remodeling and Long-term Clinical Outcomes after Transcatheter Aortic Valve Replacement Results From the Prospective POST-TAVI Registry

Presenter: Mohammad Abdelghani

September 25, 2019

Presentation TCT 2019

TAVR in Pure Aortic Regurgitation

Presenter: Thomas Pilgrim

September 25, 2019

News Opinion Fellow Talk

What I Am Most Looking Forward to at TCT 2019

Mahesh V. Madhavan, MD

September 18, 2019

News Daily News

Early Signs Positive for Tendyne TMVR in Severe MAC

Caitlin E. Cox

September 11, 2019

News Industry News

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

August 16, 2019

News Daily News

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Yael L. Maxwell

August 07, 2019

News Daily News

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Michael O'Riordan

July 17, 2019

News Daily News

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Michael O'Riordan

July 12, 2019

News Conference News TVT 2019

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Michael O'Riordan

June 20, 2019

News Conference News TVT 2019

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

Michael O'Riordan

June 19, 2019

Presentation TVT 2019

New Generation Transcatheter Heart Valve for Severe Non-Calcified Aortic Regurgitation – The Transfemoral J-Valve System

Presenter: Mark Hensey

June 14, 2019

Presentation TVT 2019

Comparison of 3D Transesophageal Echocardiogram vs. CTA for TAVR Valve Sizing and Resulting Aortic Regurgitation

Presenter: Sarfaraz Memon

June 14, 2019

Presentation TVT 2019

Case: JenaValve for Pure Aortic Regurgitation

Presenter: Torsten Vahl

June 13, 2019

Presentation TVT 2019

Case: J-Valve for Pure Aortic Regurgitation

Presenter: Jian Ye

June 13, 2019

Presentation TVT 2019

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Presenter: Vinod Thourani

June 13, 2019

Presentation TVT 2019

Transcatheter Aortic Valve Replacement Using the CoreValve Prosthesis for the Treatment of Severe Aortic Regurgitation: A Single-Center Learning Curve Over 6 Years

Presenter: Giselle Baquero

June 13, 2019

News Daily News

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Michael O'Riordan

June 12, 2019

News Daily News

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Michael O'Riordan

June 11, 2019

News Conference News EuroPCR 2019

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Caitlin E. Cox

June 07, 2019

Advertisement

Personalized CT-Derived Modeling Guides Choices in Bicuspid Aortic Valve Disease

TCT 79: Multimodality Assessment of Prosthetic Valve Regurgitation to Predict Reverse Cardiac Remodeling and Long-term Clinical Outcomes after Transcatheter Aortic Valve Replacement Results From the Prospective POST-TAVI Registry

TAVR in Pure Aortic Regurgitation

What I Am Most Looking Forward to at TCT 2019

Early Signs Positive for Tendyne TMVR in Severe MAC

Medtronic Evolut TAVR System Receives Expanded Indication to Treat Symptomatic Severe Aortic Stenosis Patients at Low Risk for Surgical Mortality

Earlier Care, More Data Needed to Increase Treatment Success in Tricuspid Regurgitation

Better Outcomes, Fewer Complications Among Higher-Volume MitraClip Sites

Elevated BP Linked to Risk of Valvular Heart Disease, Including Aortic Stenosis

Better Hemodynamics, Less Mismatch With Self-Expanding TAVR vs Surgery

Surgical Risk Should Be ‘Off the Table’ When Deciding on Eligibility for TAVR

New Generation Transcatheter Heart Valve for Severe Non-Calcified Aortic Regurgitation – The Transfemoral J-Valve System

Comparison of 3D Transesophageal Echocardiogram vs. CTA for TAVR Valve Sizing and Resulting Aortic Regurgitation

Case: JenaValve for Pure Aortic Regurgitation

Case: J-Valve for Pure Aortic Regurgitation

30-Day Outcomes From an Early Feasibility Study to Assess the Safety and Effectiveness of a Novel Transfemoral TAVR System for the Treatment of Patients With Symptomatic Severe Aortic Regurgitation (AR)

Transcatheter Aortic Valve Replacement Using the CoreValve Prosthesis for the Treatment of Severe Aortic Regurgitation: A Single-Center Learning Curve Over 6 Years

TAVR Growing in the US, but Vast Majority of Patients Not Receiving Any Form of Valve Replacement

Similar Mortality, Higher Early Stroke Risks in TAVR for Bicuspid Aortic Stenosis

Endocarditis After TAVR: Real-world Data Speak to Its Rarity but Also the ‘Devastating’ Impact

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content